Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
FitMed runs a Biotechnology Research operation from Adelaide, South Australia. It is privately held, and its site is fitmed.com. It holds five addresses on record across five office countries. Headcount on record is 6. Its work is tagged dietetics, diabetes and cancer. One Australian registration (ABN) is a candidate match. The record links five similar brands, most of them in IT Services & Consulting.
ABN13638732215
| FITMED PTY LTD | ABN 13638732215 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
FitMed is a treatment for the health system as much as it is for patients.
An entire ecosystem that delivers care as a complete platform, FitMed defines and installs a new medical layer that combines new clinical capability and adjuvant treatment, AI and biometric derived insights and interventions, and adaptive, human-centred care across all disease stages.
No other system:
- Repairs the broken “missing middle” in healthcare
- Builds capacity to meet the chronic disease crisis
- Integrates exercise medicine, disease-specific dietetics, psychosocial care, and patient education into a single, clinically governed care mesh
- Delivers that mesh via prescribable treatment, certified clinicians, and real-time, wearable-informed biometrics
The Connected Clinical Care Engine includes:
- FitMed App - enables access to clinically prescribed, self-administered adjuvants that amplify treatment and patient outcomes, dramatically improving survivability and healthspan
- FitMed Connect - delivers localised clinical support where and when it’s needed
- FitMed Academy - builds new clinical capacity and capability to deliver connected care
- FitMed Foundation - accelerates research into treatments that can be applied now, not years from now
Chronic disease is clinically complex and psychologically brutal. Patients often enter catabolic states under aggressive therapies. FitMed’s proprietary tech provides the biometric spine to adapt treatment in real time - revealing when to press forward and when to pull back.
This is governed, adaptive care, guided not by guesswork, but by precision.
✔ More life to your years - not just years to your life (Patients)
✔ More care from your work - not more work from your care (Care Teams)
✔ More outcomes to your budget - not more of your budget to outcomes (Partners)
| Countries | 5 |
|---|---|
| Primary country | AU |
All codes: AU GB JP SG US
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One South Australia entity on the ABR: FITMED PTY LTD (ABN 13 638 732 215), medium confidence.
6 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Five addresses on record across 5 countries. Primary: Friendly Society Medical Association House, Adelaide, South Australia 5000.
None linked to this brand.
17 tags on the brand's own list, among them dietetics, diabetes and cancer.
6 profiles list FitMed as a peer — 68th percentile in Biotechnology Research. It lists ten peers of its own. The Cullinan Group and NFT me list it back.